COMP <GO>
MDWD vs ISPR // RETURN ON INVESTED CAPITAL (ROIC)
MediWound Ltd. (NASDAQ) VS. Ispire Technology Inc. (NASDAQ) • 15-METRIC TALLY: MDWD 2
— ISPR 0
■ METRIC PARITY
LAST: $13.86 (+2.21%) • MKT CAP: $178.9M
roic
—
LAST: $1.37 (-1.44%) • MKT CAP: $79.1M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDWD VS. ISPR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDWD | ISPR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 17.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -10.71% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -29.70% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -30.80% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -16.10% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 46.8 | +8.37 | MDWD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $178.9M | $79.1M | $99.8M | MDWD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDWD REV | ISPR REV | MDWD GROSS % | ISPR GROSS % | MDWD FCF | ISPR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $127.5M | — | 17.8% | — | -$8.5M |
| FY 2024 | — | $151.9M | — | 19.6% | — | -$20.3M |
| FY 2023 | — | $115.6M | — | — | — | -$8.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDWD // BETA —
ISPR // BETA —